艾芬达IPO之路尘埃落定？业绩、市场、创新三大难题待解

Core Viewpoint - Jiangxi Aifenda HVAC Technology Co., Ltd. has made progress in its IPO journey, with its application for the ChiNext board being registered as effective, despite facing challenges such as performance volatility and doubts about its R&D capabilities [1][3]. IPO Journey - Aifenda's IPO process has been complicated, with its application accepted on June 20, 2022, entering the inquiry stage on July 17, 2022, and being approved on April 27, 2023. The review was suspended in May 2024 due to a change in the reporting accountant, but resumed in August 2024, leading to the registration application submitted on May 26, 2025, and the status changing to "registered effective" on June 11, 2025 [3]. - The company aims to raise approximately 665 million yuan, which will be used for upgrading automated production lines and supplementing working capital [3]. Financial Performance - Aifenda's revenue grew from 762 million yuan in 2022 to 1.05 billion yuan in 2024, with a compound annual growth rate of 17.36%. However, its net profit fluctuated significantly, with a 76.04% increase in 2023 to 164 million yuan, followed by a 28.04% decrease in 2024 to 118 million yuan [4]. - In 2023, Aifenda's other income, primarily from government subsidies, reached 59.87 million yuan, and asset disposal income was 53.87 million yuan. After excluding these non-recurring gains, the company's net profit attributable to the parent was 87.40 million yuan, indicating a decline from 2022 [5]. Accounts Receivable and Inventory - Aifenda's accounts receivable increased from 180 million yuan in 2022 to 293 million yuan in 2024, while inventory value rose to 206 million yuan, accounting for 29.73% of current assets. The rapid growth in accounts receivable may pressure cash flow and increase bad debt risk [5]. - As of the end of 2024, Aifenda had cash and cash equivalents of 136 million yuan, but short-term borrowings and current portion of non-current liabilities totaled 232 million yuan, resulting in a short-term funding gap of 96 million yuan [5]. Dependence on Overseas Markets - Aifenda is heavily reliant on overseas markets, with international sales accounting for 92.37% to 95.53% of its revenue from 2022 to 2024, and over 60% of this revenue coming from the UK market. This dependence poses risks amid increasing global economic uncertainties and potential trade protectionism [6]. - The company has faced foreign exchange losses due to settlements in USD, EUR, and GBP, with losses of 8.35 million yuan, 11.45 million yuan, and 6.42 million yuan from 2022 to 2024, respectively [7]. R&D Capabilities - Aifenda's R&D expenditure as a percentage of revenue was below the average of comparable companies, at 3.31%, 3.53%, and 3.18% from 2022 to 2024 [8]. - The educational background of Aifenda's R&D personnel raises concerns, with only 12 individuals holding a bachelor's degree or higher, making up 6.35% of the total R&D staff, while 72% have below college-level education [9][10]. Overall Assessment - Aifenda's performance is unstable, with excessive reliance on overseas markets and questioned innovation capabilities. If the company successfully goes public, it will face significant challenges in addressing these issues [11].